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coding
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specific SNPs on the prognosis of patients with COVID-19. The positions of the collected

functional relationships between microRNAs,

SNPs were compared to the positions of human miRNAs from miRBase using the hg38

their target genes, and COVID-19.
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Introduction:

start of the miRNA sequence (Figure 1). MiRNA target genes were identified using miRWalk

SARS-CoV-2 is a novel coronavirus that is
responsible for COVID-19. The infection
results in a wide range of symptoms affecting
the respiratory and cardiovascular systems
that have been noted to differ across race,
age, and sex. Because of the differing
outcomes of infection between groups, it is
critical that biomarkers are identified to
determine the aggressiveness of the infection
prior to the onset of clinical symptoms.
Single nucleotide polymorphisms (SNPs),
which are genetic variations of a single
nucleotide amongst people, have been
associated with the prognosis of COVID-19
infection. Evidence of SNPs, mostly part of
non-coding genome, having an impact on the
progression and outcome of COVID-19
infections1, suggests that they may be
involved in the regulation of the expression of
genes controlling critical biological functions
of physiological responses to viral infections.
MicroRNAs (miRNAs) are short non-coding
RNAs involved in the post-transcriptional
gene regulation by binding to target mRNA
sequences and effectively silencing gene
expression. They are involved in the
regulation of gene controlling many biological
functions including immune responses.
MiRNAs can be easily detected and
quantified in the blood; therefore they can
works as circulating biomarkers2, including
COVID-19.

2.0, miRTarBase, miRecords, and Tarbase V8. These targets were compared across miRNAs

determine

to identify similarities using RStudio, an open source software for statistical analysis.
Fig. 1
SNP and miRNA
sequence
interactions
Figure generated with BioRender

Chr 6 and Chr 19 SNPs and Respective miRNAs
1000

Chr 6 SNPs
Chr 19 SNPs

500

Distance (b)

to

0

-500

-1000

-1500
m
i
m R-6
iR 89
m -6 1
i
m R-6891 5p
iR 83 -3
m -6 2 p
i
m R-4832 5p
iR 64 -3
m -4 6 p
i
m R-1646 5p
iR 23 -3
m -1 6 p
i
m R-6236 5p
iR 72 -3
m -6 1 p
iR 83 -5
p
m 6833-5
iR 3 p
m m -31 -3p
i
m R-1 iR- 35b
iR 03 46
- 1 9 41
03 8m m 98 5p
i
m R-4 iR- 3p
iR 74 63
-4 6 7
m m 746 5p
iR iR -3
m -4 -7 p
i
m R-4747 5p
iR 74 -5
m -5 7 p
iR 58 -3
-5 9 p
m 589-5p
iR m mi - 4 3 p
i R 3
m R-1 -1 22
iR 23 18
-1 8 1
2 -3
m 38- p
m mi iR- 5p
i R 6
m R-1 -4 38
iR 99 74
m -1 a 8
i
m R-699a 5p
iR 79 -3
m -6 3 p
i
m R-6793 5p
iR 88 -3
m -6 6 p
i
m R-6886 5p
iR 79 -3
-6 8 p
m 798-5p
m iR 3
i
m R-1 -43 p
m iR- 50 24
i
m R-5150 5p
i
m R-5088 3p
iR 08 -5
m -6 8 p
i
m R-6799 3p
iR 79 -5
m -6 9 p
i
m R-6800 3p
iR 80 -5
m -4 0 p
iR 74 -3
-4 9 p
74 -5
9- p
3p

genome

miR

Fig. 2: The distance of SNPs from the start position of miRNAs. The start of a miRNA is denoted as 0 b.

Fig 3. In the process of miRNA maturation,
miRNA sequences go through processing in the
nucleus and transported in the cytoplasm. From
there, mature miRNAs can be excreted from the
cell through exosomes into the extracellular
environment (serum, plasma, etc.). The
concentration of miRNAs in these environments

HYPOTHESIS

can be measured and quantified utilizing

We hypothesized that SNPs from genomic

From reference 8.

amplification techniques.

Final results are pending. Preliminary
results revealed 115 human miRNAs in
close proximity to the studied SNPs with
notable clusters in chromosomes 6 and 19
(Figure 2).
For these miRNAs we are now analyzing
the known target messenger RNAs and
identify common signaling pathway. We
expect to discover an enrichment in
immune related signaling targets.

Conclusions:
The confirmed target genes for the
identified miRNAs will be studied using
available databases to identify their
biological significance and possible relation
to COVID-19. A target gene’s biological
significance and possible relation to
COVID-19 will be defined as having
involvement in lung structure and function,
cardiopulmonary
function,
immune
response, and cytokine release. In order to
confidently determine whether or not the
miRNAs could serve as potential
biomarkers for the prognosis and severity
of COVID-19 infection, further wet-lab
analysis of the miRNA concentrations in
control, surviving patient, and deceased
patient plasma samples is required. Plasma
samples are key samples for miRNA
analysis because miRNAs can be released
into the bloodstream through exosomes,
where miRNAs can be transported to other
cells as shown by Cortez et al’s diagram8
(Figure 3). A statistically significant
difference between the concentrations of
miRNAs in control, surviving patient, and
deceased patient samples would be
considered evidence to support the
classification of a microRNA as a biomarker
for SARS-CoV-2 infection prognosis.

regions linked to COVID-19 aggressivity

References

contains microRNAs that can be used as

1)
2)

early

biomarkers

expression) for
disease.

the

(through
evolution of

their
the

3)
4)
5)
6)
7)
8)

COVID-19 Host Genetics Initiative Nature (2021)
Anfossi et al. Nature Reviews Clinical Oncology 15, 541-563
(2018)
Pairo-Castineira et al. Nature 591, 92-98 (2021)
Zeberg et al. Nature 587, 610-612 (2020)
Wang et al. Genome Medicine (2021)
Forbester et al. Mucosal Immunology 14, 14-25 (2021)
Zhou et al Nature Medicine 27, 659-667 (2021)
Cortez et al. Nature Reviews Clinical Oncology 8, 467-477
(2011)

